Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma

Autor: Xiong, Shan, Liu, Fengjie, Sun, Jingru, Gao, Shuaixin, Wong, Catherine C.L., Tu, Ping, Wang, Yang
Zdroj: In Journal of Investigative Dermatology December 2024 144(12):2778-2788
Databáze: ScienceDirect